Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use. (2020)

First Author: Blunt MD
Attributed to:  Targeting natural killer cell receptors for immunotherapeutic benefit funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/iji.12461

PubMed Identifier: 31755661

Publication URI: http://europepmc.org/abstract/MED/31755661

Type: Journal Article/Review

Volume: 47

Parent Publication: International journal of immunogenetics

Issue: 1

ISSN: 1744-3121